Clogged pores for increased effectiveness: Whey protein stabilizes nanotransporter, controls pH-dependent drug release

Jan 17, 2013

(—How can pharmaceuticals be safely carried through the acidic environment of the stomach and into the intestines? A team of Canadian and Australian researchers has developed a novel nanotransporter that consists of porous particles of silicon dioxide stabilized with a whey protein. In acidic environments the protein forms a gel that closes off the pores; at higher pH values, the pores are opened.

For pharmaceuticals, both the drug itself and its form of delivery are important, as the latter determines where and when the drug becomes active in the body. For example, extended-release formulations are designed to maintain a steady level of the drug over a longer period of time and antitumor drugs are meant to become active in as selectively as possible in order to minimize side effects. To make this work the drugs have to be "packaged" correctly. Packaging is also often required for medications administered orally because many drugs are destroyed by before they can reach the intestine to be absorbed into the bloodstream. However, the protection against acid must also release the drug under the conditions found in the intestine.

One highly promising type of drug "package" is the mesoporous silicon dioxide nanoparticle. These are biocompatible and easy to make with the required pore and particle sizes. The chemistry of their inner and outer surfaces can easily be modified, they can easily be loaded with of various sizes, and these can in turn be released in a controlled fashion. However, these particles have a tendency to aggregate under physiological conditions, which can completely change their properties. Also, new methods must be developed to ensure selective release at the desired target. The change in pH in the transition from stomach to intestine is a potential trigger.

A team led by Shi Zhang Qiao at the University of Queensland (Brisbane, Australia) and Freddy Kleitz at the Université Laval (Quebec, Canada) has now refined some nanotransporters, they report in the journal Angewandte Chemie. Their success stems from their use of β-lactoglobulin, a whey protein used as a dietary supplement. The researchers attached this to the outer surface of the porous nanoparticles, preventing their aggregation and increasing their biocompatibility. At pH values below 5, like those found in the stomach, β-lactoglobulin gels: it swells up and forms a gelatin "shell" around the nanoparticles, which clogs the pores and prevents the drug from exiting. At higher pH values like those in the intestines, the protein assumes the form of discrete molecules, opening the and releasing the drug.

As well as the stomach and intestine, other organs also have different pH values—and there are even pH differences between certain tumors and the surrounding healthy tissue. Further development of this new procedure may possibly be used to make nanotransporters capable of reacting to such subtler pH gradients.

Explore further: Experts cautious over Google nanoparticle project

More information: Guillet-Nicolas, R. et al. pH-Responsive Nutraceutical–Mesoporous Silica Nanoconjugates with Enhanced Colloidal Stability, Angewandte Chemie International Edition.

Related Stories

Study finds more gut reaction to arthritis drugs

Sep 01, 2011

Patients often take drugs to lower stomach acid and reduce the chances they will develop ulcers from taking their anti-inflammatory drugs for conditions such as arthritis, but the combination may be causing major problems ...

Recommended for you

Nanosafety research: The quest for the gold standard

Oct 29, 2014

Empa toxicologist Harald Krug has lambasted his colleagues in the journal Angewandte Chemie. He evaluated several thousand studies on the risks associated with nanoparticles and discovered no end of shortc ...

New nanodevice to improve cancer treatment monitoring

Oct 27, 2014

In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten ...

Molecular beacons shine light on how cells 'crawl'

Oct 24, 2014

Adherent cells, the kind that form the architecture of all multi-cellular organisms, are mechanically engineered with precise forces that allow them to move around and stick to things. Proteins called integrin ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.